This is not the most recent version of the article. View current version (3 JUN 2014)

Intervention Protocol

You have free access to this content

Anticoagulation therapy versus placebo for pulmonary hypertension

  1. Ifeanyi Ezedunukwe1,*,
  2. Hilary Enuh2,
  3. Jay Nfonoyim3,
  4. Collins U Enuh4

Editorial Group: Cochrane Airways Group

Published Online: 5 AUG 2013

DOI: 10.1002/14651858.CD010695


How to Cite

Ezedunukwe I, Enuh H, Nfonoyim J, Enuh CU. Anticoagulation therapy versus placebo for pulmonary hypertension (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD010695. DOI: 10.1002/14651858.CD010695.

Author Information

  1. 1

    Lagos University Teaching Hospital, Department of Medicine, Lagos, Nigeria

  2. 2

    Richmond University Medical Center, Department of Internal Medicine, New York, USA

  3. 3

    Richmond University Medical Center, Intensive Care Unit, New York, USA

  4. 4

    University of Abuja Teaching Hospital, Department of Anaesthesia, Abuja, Nigeria

*Ifeanyi Ezedunukwe, Department of Medicine, Lagos University Teaching Hospital, Lagos, Nigeria. ifeanyiezedunukwe@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 5 AUG 2013

SEARCH

This is not the most recent version of the article. View current version (03 JUN 2014)

References

Additional references

Badesch 2009
  • Badesch BD, Champion HC, Gomez-Sanchez MA, Hoeper M, Loyd J, Manes A, et al. Diagnosis and assessment of pulmonary arterial hypertension. Journal of the American College of Cardiology 2009;54:S55-6.
Barst 2009
  • Barst RJ, Gibbs JS, Ghofrani HA, Hoeper MM, McLaughlin VV, Rubin LJ, et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. Journal of the American College of Cardiology 2009;54(1 Suppl):S78.
Bedard 2009
  • Bedard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?. European Heart Journal 2009;30:256-65.
Bjornsson 1985
  • Bjornsson J, Edwards WD. Primary pulmonary hypertension:a histopathologic study of 80 cases. Mayo Clinic Proceedings 1985;60:16-25.
D'Alonzo 1991
  • D’Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Annals of Internal Medicine 1991;115:343-9.
DiMarco 2005
  • DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, et al. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. American Heart Journal 2005;149:650-5.
Duchini 1998
  • Duchini A, Sessoms SL. Gastrointestinal hemorrhage inpatients with systemic sclerosis and CREST syndrome. American Journal of Gastroenterology 1998;93:1453-6.
    Direct Link:
Fuster 1984
  • Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984;70:580-7.
Galie 2009
  • Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). ESC Committee for Practice Guidelines (CPG) European Heart Journal 2009;30(20):2493.
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Humbert 2004
  • Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. Journal of the American College of Cardiology 2004;43(12 Suppl S):13. [PUBMED: 15194174 ]
Humbert 2006
  • Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, et al. Pulmonary arterial hypertension in France: results from a national registry. American Journal of Respiratory Care Medicine 2006;173(9):1023.
Johnson 2006
Johnson 2006B
Johnson 2012
  • Johnson SR, Granton JT, Tomlinson GA, Grosbein HA, Le T, Lee P, et al. Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease. Journal of Rheumatology 2012;39(2):276-85. [DOI: 10.3899/jrheum.110765]
Kovasc 2009
Ling 2012
  • Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JS, et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. American Journal of Respiratory Critical Care Medicine 2012;186(8):790.
Marcus 2008
  • Marcus JT, Gan CT, Zwanenburg JJ, Boonstra A, Allaart CP, Gotte MJW. Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. Journal of the American College of Cardiology 2008;51:750-7.
McLaughlin 2009
  • McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. ACCF/AHA Circulation 2009;119(16):2250.
Murphey 2003
Ogawa 2005
  • Ogawa A, Matsubara H, Fujio H, Miyaji K, Nakamura K, Morita H, et al. Risk of alveolar hemorrhage in patients with primary pulmonary hypertension – anticoagulation and epoprostenol therapy. Circulation Journal: official Journal of the Japanese Circulation Society 2005;69:216-20.
Paulus 2007
  • Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography. European Heart Journal 2007;28:2539-50.
Peacock 2007
Pietra 2004
  • Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. Journal of the American College of Cardiology 2004;43(12 Suppl S):25. [PUBMED: 15194175]
Review Manager (RevMan) 2012
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Rich 1998
  • Rich S. Executive summary from the World Symposium on Primary Pulmonary Hypertension, Evian, France, co-sponsored by The World Health Organization. World Symposium on Primary Pulmonary Hypertension, Evian, France, co-sponsored by The World Health Organization September 6-10, 1998.
Simoneau 2009
  • Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. Updated clinical classification of pulmonary hypertension. Journal of the American College of Cardiology 2009;54:S43.
Thenappan 2007
Torbicki 2007
Wagenvoort 1980
Widlitz 2005
  • Widlitz AC, Barst RJ, Horn EM. Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertension. Expert Review of Cardiovascular Therapy 2005;3:985-91.